View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Kemwell
8 September 2014

New CEO of Swedish Operations Announced by Kemwell AB

Kemwell AB, part of the Kemwell group, which is a contract pharmaceutical development and manufacturing company with facilities in Sweden, India and the US, has announced the appointment of Mikael Ericson as the new CEO of its Swedish operations.

Mikael assumed responsibilities on 1 September 2014, and will succeed Agneta Bergvall. Mikael Ericson is highly experienced in production, logistics and lean management. He has held various international management positions in large corporations in both pharmaceutical and automotive industries, such as AstraZeneca, Scania and Plastal Industri with success.

He has achieved great productivity improvements year on year by introducing lean ways of working and engaging people in process development and continuous improvements while always maintaining a strong focus on the customer.

"With his in-depth technical and business background, Mikael will be an excellent leader for taking the company to the next level together along with Kemwell’s experienced associates," said the chairman of the board, PerAke Oldentoft.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena